SlideShare a Scribd company logo
MR. SAMBAD JAGDISH.G
B.SC.(N)-ACLS-BLS-BLSO-ITLS - CMS.ED,
M.SC. NURSING
BALAJI COLLEGE OF NURSING
HIV.AIDS
RECENT FACTS ABOUT: HIV
 Global World AIDS Day 2017 campaign which
promotes the theme "Right to health", the World
Health Organization will highlight the need for all 36.7
million people living with HIV and those who are
vulnerable and affected by the epidemic, to reach the
goal of universal health coverage.
 Under the slogan "Everybody counts", WHO will
advocate for access to safe, effective, quality and
affordable medicines, including medicines, diagnostics
and other health commodities as well as health care
services for all people in need, while also ensuring that
they are protected against financial risks.
Key messages of world health organization
- to achieve universal health coverage
 Leave no one behind.
 HIV, tuberculosis and hepatitis services are
integrated.
 High-quality services are available for those with
HIV.
 People living with HIV have access to affordable
care.
 The HIV response is robust and leads to stronger
health systems
WHAT IS HIV?
 “Human Immunodeficiency Virus”
 A unique type of virus (a retrovirus)
 Invades the helper T cells (CD4 cells) in the body of
the host (defense mechanism of a person)
 Threatening a global epidemic.
 Preventable, managable but not curable.
OTHER NAMES FOR HIV
 Former names of the virus include:
 Human T cell lymphotrophic virus (HTLV-III)
 Lymphadenopathy associated virus (LAV)
 AIDS associated retrovirus (ARV)
WHAT IS AIDS ???
 “Acquired Immunodeficiency Syndrome”
 HIV is the virus that causes AIDS
 Disease limits the body’s ability to fight infection
due to markedly reduced helper T cells.
 Patients have a very weak immune system (defense
mechanism)
 Patients predisposed to multiple opportunistic
infections leading to death.
AIDS (definition)
 Opportunistic infections and malignancies that
rarely occur in the absence of severe
immunodeficiency (eg, Pneumocystis pneumonia,
central nervous system lymphoma).
 Persons with positive HIV serology who have ever
had a CD4 lymphocyte count below 200 cells/mcL or
a CD4 lymphocyte percentage below 14% are
considered to have AIDS.
“THE VIRAL GENOME”
 Icosahedral (20 sided), enveloped virus of the
lentivirus subfamily of retroviruses.
 Retroviruses transcribe RNA to DNA.
Two viral strands of RNA
found in core surrounded by
protein outer coat.
Outer envelope contains a lipid
matrix within which specific
viral glycoproteins are
imbedded.
These knob-like structures
responsible for binding to
target cell.
oBODY FLUIDS
oINTERAVENUS DRUG ABSUE
oTHROUGH SEX
oMOTHER TO BABY
Modes of HIV/AIDS
Transmission
Through Bodily Fluids
 Blood products
 Semen
 Vaginal fluids
Intravenous Drug Abuse
 Sharing Needles
 Without sterilization Increases the chances of
contracting HIV
 Unsterilized blades
Through Sex
 Unprotected Intercourse
 Oral
 Anal
Mother-to-Baby
 Before Birth
 During Birth
HOW YOU DO NOT GET HIV INFECTION ?
 Not by bitten by mosquito or other drug
 Not by bitten by an animal
 Not by eating food handled prepared or served by
someone infected with HIV
 Not by sharing toilets ,telephones or cloths
 Not by touching, hugging ,or kissing a person with HIV
infection
 Not by attending school, participating sports, church,
shoppingmalls,or other public places with HIV infected
people
NATURAL COURSE OF
HIV/AIDS
Stage 1 - Primary
 Short, flu-like illness
- occurs one to six
weeks after infection
 Mild symptoms
 Infected person can
infect other people
Stage 2 - Asymptomatic
 Lasts for an average of ten years
 This stage is free from symptoms
 There may be swollen glands
 The level of HIV in the blood drops to low
levels
 HIV antibodies are detectable in the blood
Stage 3 - Symptomatic
 The immune system deteriorates
 Opportunistic infections and cancers start to
appear.
Stage 4 - HIV  AIDS
 The immune system
weakens too much as
CD4 cells decrease in
number.
Opportunistic Infections associated with AIDS
CD4<500
 Bacterial infections
 Tuberculosis (TB)
 Herpes Simplex
 Herpes Zoster
 Vaginal candidiasis
 Hairy leukoplakia
 Kaposi’s sarcoma
Opportunistic Infections associated with AIDS
CD4<200
 Pneumocystic carinii
 Toxoplasmosis
 Cryptococcosis
 Coccidiodomycosis
 Cryptosporiosis
 Non hodgkin’s
lymphoma
CD4 <50
 Disseminated mycobacterium avium complex (MAC)
infection
 Histoplasmosis
 CMV retinitis
 CNS lymphoma
 Progressive multifocal leukoencephalopathy
 HIV dementia
TB & HIV CO-INFECTION
 TB is the most common opportunistic infection in HIV and
the first cause of mortality in HIV infected patients (10-
30%)
 10 million patients co-infected in the world.
 Immunosuppression induced by HIV modifies the
clinical presentation of TB :
1. Subnormal clinical and roentgen presentation
2. High rate of MDR/XDR
3. High rate of treatment failure and relapse (5% vs < 1% in HIV)
Testing Options for HIV
Anonymous Testing
 No name is used
 Unique identifying number
 Results issued only to test recipient
23659874515
Anonymous
Blood Detection Tests
HIV enzyme-linked
immunosorbent assay (ELISA)
Screening test for HIV
Sensitivity > 99.9%
Western blot Confirmatory test
Specificity > 99.9% (when combined with ELIZA)
HIV rapid antibody test Screening test for HIV
Simple to perform
Absolute CD4 lymphocyte count Predictor of HIV progression
Risk of opportunistic infections and AIDS when
<200
HIV viral load tests Best test for diagnosis of acute HIV infection
Correlates with disease progression and
response to HAART
Urine Testing
 Urine Western Blot
 As sensitive as testing blood
 Safe way to screen for HIV
 Can cause false positives in certain
people at high risk for HIV
Oral Testing
 Orasure
 The only FDA approved HIV
antibody.
 As accurate as blood testing
 Draws blood-derived fluids
from the gum tissue.
 NOT A SALIVA TEST!
Treatment Options
HAART = highly active anti-retroviral treatment
Antiretroviral Drugs (HAART)
 Nucleoside Reverse Transcriptase inhibitors
 AZT (Zidovudine)
 Non-Nucleoside Transcriptase inhibitors
 Viramune (Nevirapine)
 Protease inhibitors
 Norvir (Ritonavir)
HEALTH CARE FOLLOW UP OF HIV
INFECTED PATIENTS
For all HIV-infected individuals:
 CD4 counts every 3–6 months
 Viral load tests every 3–6 months and 1 month following a change in therapy
 PPD
 INH for those with positive PPD and normal chest radiograph
 RPR or VDRL for syphilis
 Toxoplasma IgG serology
 Cytomegalo virus IgG serology
 Pneumococcal vaccine
 Influenza vaccine in season
 Hepatitis B vaccine for those who are HBsAb-negative
 Haemophilus influenzae type b vaccination
 Papanicolaou (cervical )smears every 6 months for women
Conti…
 For HIV-infected individuals with CD4 < 200
cells/mcL:
 Pneumocystis jiroveci1 prophylaxis
 For HIV-infected individuals with CD4 < 75
cells/mcL:
 Mycobacterium avium complex prophylaxis
 For HIV-infected individuals with CD4 < 50
cells/mcL:
 Consider CMV prophylaxis
PRIMARY PREVENTION:
Five ways to protect yourself?
 Abstinence
 Monogamous Relationship
 Protected Sex
 Sterile needles
 New shaving/cutting blades
Abstinence
 It is the most effective method of not acquiring
HIV/AIDS.
 Refraining from unprotected sex: oral, anal, or
vaginal.
 Refraining from intravenous drug use
Monogamous relationship
 A mutually monogamous (only one sex
partner) relationship with a person who is not
infected with HIV
 HIV testing before intercourse is necessary to
prove your partner is not infected
Protected Sex
 Use condoms every time you have
sex
 Always use latex or polyurethane
condom (not a natural skin
condom)
 Always use a latex barrier during
oral sex
When Using A Condom Remember To:
 Make sure the package is
not expired
 Make sure to check the
package for damages
 Do not open the package
with your teeth for risk of
tearing
 Never use the condom
more than once
 Use water-based rather
than oil-based condoms
WHAT WE CAN DO??
UNAIDS Outcome Framework 2009–2011: nine priority areas
 We can reduce sexual transmission of HIV.
 We can prevent mothers from dying and babies from becoming infected with
HIV.
 We can ensure that people living with HIV receive treatment.
 We can prevent people living with HIV from dying of tuberculosis.
 We can protect drug users from becoming infected with HIV.
 We can remove punitive laws, policies, practices, stigma and discrimination
that
 block effective responses to AIDS.
 We can stop violence against women and girls.
 We can empower young people to protect themselves from HIV.
 We can enhance social protection for people affected by HIV.
LIVING WITH HIV/AIDS
HIV-AIDS.ppt
HIV-AIDS.ppt

More Related Content

What's hot

GEMC - HIV/AIDS - for Nurses
GEMC - HIV/AIDS - for NursesGEMC - HIV/AIDS - for Nurses
GEMC - HIV/AIDS - for Nurses
Open.Michigan
 
Prevention Of HIV/AIDS
Prevention Of HIV/AIDSPrevention Of HIV/AIDS
Prevention Of HIV/AIDS
Soumar Dutta
 
Measles
MeaslesMeasles
AIDS
AIDSAIDS
HIV/AIDS Management
HIV/AIDS ManagementHIV/AIDS Management
HIV/AIDS Management
Sameh Abdel-ghany
 
typhoid fever
typhoid fevertyphoid fever
typhoid fever
UgbadMuuse
 
Dengue
DengueDengue
Dengue
KULDEEP VYAS
 
HIV INFECTION
HIV INFECTIONHIV INFECTION
HIV INFECTION
swathisravani
 
Measles
MeaslesMeasles
HIV/AIDS
HIV/AIDSHIV/AIDS
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
Liezle Joy Gargoles
 
AIDS
AIDSAIDS
Immunoprophylaxis and Immunization
Immunoprophylaxis and ImmunizationImmunoprophylaxis and Immunization
Immunoprophylaxis and Immunization
saheli chakraborty
 
Measles
MeaslesMeasles
Influenza: Symptoms, causes, treatment and prevention
Influenza: Symptoms, causes, treatment and preventionInfluenza: Symptoms, causes, treatment and prevention
Influenza: Symptoms, causes, treatment and prevention
Lazoi Lifecare Private Limited
 
Smallpox
SmallpoxSmallpox
Smallpox
OM VERMA
 
AIDS
AIDS AIDS
Malaria
MalariaMalaria
HIV-AIDS-Prevention & Control
HIV-AIDS-Prevention & ControlHIV-AIDS-Prevention & Control
HIV/Aids
HIV/AidsHIV/Aids

What's hot (20)

GEMC - HIV/AIDS - for Nurses
GEMC - HIV/AIDS - for NursesGEMC - HIV/AIDS - for Nurses
GEMC - HIV/AIDS - for Nurses
 
Prevention Of HIV/AIDS
Prevention Of HIV/AIDSPrevention Of HIV/AIDS
Prevention Of HIV/AIDS
 
Measles
MeaslesMeasles
Measles
 
AIDS
AIDSAIDS
AIDS
 
HIV/AIDS Management
HIV/AIDS ManagementHIV/AIDS Management
HIV/AIDS Management
 
typhoid fever
typhoid fevertyphoid fever
typhoid fever
 
Dengue
DengueDengue
Dengue
 
HIV INFECTION
HIV INFECTIONHIV INFECTION
HIV INFECTION
 
Measles
MeaslesMeasles
Measles
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
AIDS
AIDSAIDS
AIDS
 
Immunoprophylaxis and Immunization
Immunoprophylaxis and ImmunizationImmunoprophylaxis and Immunization
Immunoprophylaxis and Immunization
 
Measles
MeaslesMeasles
Measles
 
Influenza: Symptoms, causes, treatment and prevention
Influenza: Symptoms, causes, treatment and preventionInfluenza: Symptoms, causes, treatment and prevention
Influenza: Symptoms, causes, treatment and prevention
 
Smallpox
SmallpoxSmallpox
Smallpox
 
AIDS
AIDS AIDS
AIDS
 
Malaria
MalariaMalaria
Malaria
 
HIV-AIDS-Prevention & Control
HIV-AIDS-Prevention & ControlHIV-AIDS-Prevention & Control
HIV-AIDS-Prevention & Control
 
HIV/Aids
HIV/AidsHIV/Aids
HIV/Aids
 

Similar to HIV-AIDS.ppt

Hiv
HivHiv
AIDS PRESENTATION
AIDS PRESENTATIONAIDS PRESENTATION
AIDS PRESENTATION
Lopamudra Behera
 
Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024
Motahar Alam
 
Hiv aids epidemiology & trends
Hiv aids epidemiology & trendsHiv aids epidemiology & trends
Hiv aids epidemiology & trends
S A Tabish
 
Hiv transmission
Hiv transmissionHiv transmission
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
Nikhil Oza
 
aids-150808104852-lva1-app6892.pdf
aids-150808104852-lva1-app6892.pdfaids-150808104852-lva1-app6892.pdf
aids-150808104852-lva1-app6892.pdf
fatemehbemana1
 
HIV/AIDS
HIV/AIDS HIV/AIDS
Hiv dr.tanushka
Hiv dr.tanushkaHiv dr.tanushka
Hiv dr.tanushka
Tanushka kandwal
 
Hiv 2011
Hiv 2011Hiv 2011
Hiv 2011
Mohamed Gamal
 
aids day
aids day aids day
aids day
dobari
 
HIV (Durgapur Steel Plant Hospital) 01 dec 09
HIV (Durgapur Steel Plant Hospital) 01 dec 09HIV (Durgapur Steel Plant Hospital) 01 dec 09
HIV (Durgapur Steel Plant Hospital) 01 dec 09
Ratnadeep Ganguly
 
Ne waids day (2)
Ne waids day (2)Ne waids day (2)
Ne waids day (2)
uttam goswami
 
AIDA Acquired Immuno Deficiency Syndrome
AIDA Acquired Immuno Deficiency Syndrome AIDA Acquired Immuno Deficiency Syndrome
AIDA Acquired Immuno Deficiency Syndrome
AyeshaIftikharbc
 
AIDS
AIDSAIDS
Hiv 201111111
Hiv 201111111Hiv 201111111
Hiv 201111111
Mohamed Gamal
 
Aids presentation
Aids presentationAids presentation
Aids presentation
angelvizzu
 
HIV AIDS skin manifestations n management .pptx
HIV AIDS skin manifestations n management .pptxHIV AIDS skin manifestations n management .pptx
HIV AIDS skin manifestations n management .pptx
AbhishekGupta920331
 
Management of patient with AIDS
Management of patient with AIDSManagement of patient with AIDS
Management of patient with AIDS
Mathew Varghese V
 
Hiv opportunistic infections
Hiv opportunistic infectionsHiv opportunistic infections
Hiv opportunistic infections
Johnbosco (Jay Bee)
 

Similar to HIV-AIDS.ppt (20)

Hiv
HivHiv
Hiv
 
AIDS PRESENTATION
AIDS PRESENTATIONAIDS PRESENTATION
AIDS PRESENTATION
 
Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024Epidemiology of HIV & AIDS.pptx presentation 2024
Epidemiology of HIV & AIDS.pptx presentation 2024
 
Hiv aids epidemiology & trends
Hiv aids epidemiology & trendsHiv aids epidemiology & trends
Hiv aids epidemiology & trends
 
Hiv transmission
Hiv transmissionHiv transmission
Hiv transmission
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
 
aids-150808104852-lva1-app6892.pdf
aids-150808104852-lva1-app6892.pdfaids-150808104852-lva1-app6892.pdf
aids-150808104852-lva1-app6892.pdf
 
HIV/AIDS
HIV/AIDS HIV/AIDS
HIV/AIDS
 
Hiv dr.tanushka
Hiv dr.tanushkaHiv dr.tanushka
Hiv dr.tanushka
 
Hiv 2011
Hiv 2011Hiv 2011
Hiv 2011
 
aids day
aids day aids day
aids day
 
HIV (Durgapur Steel Plant Hospital) 01 dec 09
HIV (Durgapur Steel Plant Hospital) 01 dec 09HIV (Durgapur Steel Plant Hospital) 01 dec 09
HIV (Durgapur Steel Plant Hospital) 01 dec 09
 
Ne waids day (2)
Ne waids day (2)Ne waids day (2)
Ne waids day (2)
 
AIDA Acquired Immuno Deficiency Syndrome
AIDA Acquired Immuno Deficiency Syndrome AIDA Acquired Immuno Deficiency Syndrome
AIDA Acquired Immuno Deficiency Syndrome
 
AIDS
AIDSAIDS
AIDS
 
Hiv 201111111
Hiv 201111111Hiv 201111111
Hiv 201111111
 
Aids presentation
Aids presentationAids presentation
Aids presentation
 
HIV AIDS skin manifestations n management .pptx
HIV AIDS skin manifestations n management .pptxHIV AIDS skin manifestations n management .pptx
HIV AIDS skin manifestations n management .pptx
 
Management of patient with AIDS
Management of patient with AIDSManagement of patient with AIDS
Management of patient with AIDS
 
Hiv opportunistic infections
Hiv opportunistic infectionsHiv opportunistic infections
Hiv opportunistic infections
 

More from MR. JAGDISH SAMBAD

Burn injury
Burn injuryBurn injury
Burn injury
MR. JAGDISH SAMBAD
 
Phagocytic dysfunction
Phagocytic dysfunctionPhagocytic dysfunction
Phagocytic dysfunction
MR. JAGDISH SAMBAD
 
T cell defficiencies
T cell defficienciesT cell defficiencies
T cell defficiencies
MR. JAGDISH SAMBAD
 
B cell defficincies
B cell defficinciesB cell defficincies
B cell defficincies
MR. JAGDISH SAMBAD
 
Polycythemia
PolycythemiaPolycythemia
Polycythemia
MR. JAGDISH SAMBAD
 
Thalassemia
Thalassemia Thalassemia
Thalassemia
MR. JAGDISH SAMBAD
 
IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
IDIOPATHIC THROMBOCYTOPENIC PURPURA  (ITP)IDIOPATHIC THROMBOCYTOPENIC PURPURA  (ITP)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
MR. JAGDISH SAMBAD
 
Hemorrhage and shock
Hemorrhage and shock Hemorrhage and shock
Hemorrhage and shock
MR. JAGDISH SAMBAD
 
Hemophilia
Hemophilia Hemophilia
Hemophilia
MR. JAGDISH SAMBAD
 
Ulcerative Colitis
Ulcerative Colitis Ulcerative Colitis
Ulcerative Colitis
MR. JAGDISH SAMBAD
 
Intestinal Obstruction
Intestinal ObstructionIntestinal Obstruction
Intestinal Obstruction
MR. JAGDISH SAMBAD
 
Hernia
HerniaHernia
Diarrheal disease
Diarrheal diseaseDiarrheal disease
Diarrheal disease
MR. JAGDISH SAMBAD
 
Acute Pancreatitis
Acute Pancreatitis Acute Pancreatitis
Acute Pancreatitis
MR. JAGDISH SAMBAD
 
Gastritis
Gastritis Gastritis
Gastritis
MR. JAGDISH SAMBAD
 
Cirrhosis of liver
Cirrhosis of liverCirrhosis of liver
Cirrhosis of liver
MR. JAGDISH SAMBAD
 
Cholelithiasis (Gall stone)
Cholelithiasis (Gall stone)Cholelithiasis (Gall stone)
Cholelithiasis (Gall stone)
MR. JAGDISH SAMBAD
 
Body system change in elderly
Body system change in elderlyBody system change in elderly
Body system change in elderly
MR. JAGDISH SAMBAD
 
Renal stone
Renal stone Renal stone
Renal stone
MR. JAGDISH SAMBAD
 
Diabetis insipidus
Diabetis insipidusDiabetis insipidus
Diabetis insipidus
MR. JAGDISH SAMBAD
 

More from MR. JAGDISH SAMBAD (20)

Burn injury
Burn injuryBurn injury
Burn injury
 
Phagocytic dysfunction
Phagocytic dysfunctionPhagocytic dysfunction
Phagocytic dysfunction
 
T cell defficiencies
T cell defficienciesT cell defficiencies
T cell defficiencies
 
B cell defficincies
B cell defficinciesB cell defficincies
B cell defficincies
 
Polycythemia
PolycythemiaPolycythemia
Polycythemia
 
Thalassemia
Thalassemia Thalassemia
Thalassemia
 
IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
IDIOPATHIC THROMBOCYTOPENIC PURPURA  (ITP)IDIOPATHIC THROMBOCYTOPENIC PURPURA  (ITP)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
 
Hemorrhage and shock
Hemorrhage and shock Hemorrhage and shock
Hemorrhage and shock
 
Hemophilia
Hemophilia Hemophilia
Hemophilia
 
Ulcerative Colitis
Ulcerative Colitis Ulcerative Colitis
Ulcerative Colitis
 
Intestinal Obstruction
Intestinal ObstructionIntestinal Obstruction
Intestinal Obstruction
 
Hernia
HerniaHernia
Hernia
 
Diarrheal disease
Diarrheal diseaseDiarrheal disease
Diarrheal disease
 
Acute Pancreatitis
Acute Pancreatitis Acute Pancreatitis
Acute Pancreatitis
 
Gastritis
Gastritis Gastritis
Gastritis
 
Cirrhosis of liver
Cirrhosis of liverCirrhosis of liver
Cirrhosis of liver
 
Cholelithiasis (Gall stone)
Cholelithiasis (Gall stone)Cholelithiasis (Gall stone)
Cholelithiasis (Gall stone)
 
Body system change in elderly
Body system change in elderlyBody system change in elderly
Body system change in elderly
 
Renal stone
Renal stone Renal stone
Renal stone
 
Diabetis insipidus
Diabetis insipidusDiabetis insipidus
Diabetis insipidus
 

Recently uploaded

Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 

HIV-AIDS.ppt

  • 1.
  • 2. MR. SAMBAD JAGDISH.G B.SC.(N)-ACLS-BLS-BLSO-ITLS - CMS.ED, M.SC. NURSING BALAJI COLLEGE OF NURSING HIV.AIDS
  • 3.
  • 4.
  • 5. RECENT FACTS ABOUT: HIV  Global World AIDS Day 2017 campaign which promotes the theme "Right to health", the World Health Organization will highlight the need for all 36.7 million people living with HIV and those who are vulnerable and affected by the epidemic, to reach the goal of universal health coverage.  Under the slogan "Everybody counts", WHO will advocate for access to safe, effective, quality and affordable medicines, including medicines, diagnostics and other health commodities as well as health care services for all people in need, while also ensuring that they are protected against financial risks.
  • 6. Key messages of world health organization - to achieve universal health coverage  Leave no one behind.  HIV, tuberculosis and hepatitis services are integrated.  High-quality services are available for those with HIV.  People living with HIV have access to affordable care.  The HIV response is robust and leads to stronger health systems
  • 7. WHAT IS HIV?  “Human Immunodeficiency Virus”  A unique type of virus (a retrovirus)  Invades the helper T cells (CD4 cells) in the body of the host (defense mechanism of a person)  Threatening a global epidemic.  Preventable, managable but not curable.
  • 8. OTHER NAMES FOR HIV  Former names of the virus include:  Human T cell lymphotrophic virus (HTLV-III)  Lymphadenopathy associated virus (LAV)  AIDS associated retrovirus (ARV)
  • 9.
  • 10.
  • 11. WHAT IS AIDS ???  “Acquired Immunodeficiency Syndrome”  HIV is the virus that causes AIDS  Disease limits the body’s ability to fight infection due to markedly reduced helper T cells.  Patients have a very weak immune system (defense mechanism)  Patients predisposed to multiple opportunistic infections leading to death.
  • 12. AIDS (definition)  Opportunistic infections and malignancies that rarely occur in the absence of severe immunodeficiency (eg, Pneumocystis pneumonia, central nervous system lymphoma).  Persons with positive HIV serology who have ever had a CD4 lymphocyte count below 200 cells/mcL or a CD4 lymphocyte percentage below 14% are considered to have AIDS.
  • 13. “THE VIRAL GENOME”  Icosahedral (20 sided), enveloped virus of the lentivirus subfamily of retroviruses.  Retroviruses transcribe RNA to DNA. Two viral strands of RNA found in core surrounded by protein outer coat. Outer envelope contains a lipid matrix within which specific viral glycoproteins are imbedded. These knob-like structures responsible for binding to target cell.
  • 14.
  • 15. oBODY FLUIDS oINTERAVENUS DRUG ABSUE oTHROUGH SEX oMOTHER TO BABY Modes of HIV/AIDS Transmission
  • 16. Through Bodily Fluids  Blood products  Semen  Vaginal fluids
  • 17. Intravenous Drug Abuse  Sharing Needles  Without sterilization Increases the chances of contracting HIV  Unsterilized blades
  • 18. Through Sex  Unprotected Intercourse  Oral  Anal
  • 20. HOW YOU DO NOT GET HIV INFECTION ?  Not by bitten by mosquito or other drug  Not by bitten by an animal  Not by eating food handled prepared or served by someone infected with HIV  Not by sharing toilets ,telephones or cloths  Not by touching, hugging ,or kissing a person with HIV infection  Not by attending school, participating sports, church, shoppingmalls,or other public places with HIV infected people
  • 21.
  • 23. Stage 1 - Primary  Short, flu-like illness - occurs one to six weeks after infection  Mild symptoms  Infected person can infect other people
  • 24. Stage 2 - Asymptomatic  Lasts for an average of ten years  This stage is free from symptoms  There may be swollen glands  The level of HIV in the blood drops to low levels  HIV antibodies are detectable in the blood
  • 25. Stage 3 - Symptomatic  The immune system deteriorates  Opportunistic infections and cancers start to appear.
  • 26. Stage 4 - HIV  AIDS  The immune system weakens too much as CD4 cells decrease in number.
  • 27. Opportunistic Infections associated with AIDS CD4<500  Bacterial infections  Tuberculosis (TB)  Herpes Simplex  Herpes Zoster  Vaginal candidiasis  Hairy leukoplakia  Kaposi’s sarcoma
  • 28. Opportunistic Infections associated with AIDS CD4<200  Pneumocystic carinii  Toxoplasmosis  Cryptococcosis  Coccidiodomycosis  Cryptosporiosis  Non hodgkin’s lymphoma
  • 29. CD4 <50  Disseminated mycobacterium avium complex (MAC) infection  Histoplasmosis  CMV retinitis  CNS lymphoma  Progressive multifocal leukoencephalopathy  HIV dementia
  • 30. TB & HIV CO-INFECTION  TB is the most common opportunistic infection in HIV and the first cause of mortality in HIV infected patients (10- 30%)  10 million patients co-infected in the world.  Immunosuppression induced by HIV modifies the clinical presentation of TB : 1. Subnormal clinical and roentgen presentation 2. High rate of MDR/XDR 3. High rate of treatment failure and relapse (5% vs < 1% in HIV)
  • 31.
  • 32.
  • 33.
  • 34.
  • 36. Anonymous Testing  No name is used  Unique identifying number  Results issued only to test recipient 23659874515 Anonymous
  • 37. Blood Detection Tests HIV enzyme-linked immunosorbent assay (ELISA) Screening test for HIV Sensitivity > 99.9% Western blot Confirmatory test Specificity > 99.9% (when combined with ELIZA) HIV rapid antibody test Screening test for HIV Simple to perform Absolute CD4 lymphocyte count Predictor of HIV progression Risk of opportunistic infections and AIDS when <200 HIV viral load tests Best test for diagnosis of acute HIV infection Correlates with disease progression and response to HAART
  • 38. Urine Testing  Urine Western Blot  As sensitive as testing blood  Safe way to screen for HIV  Can cause false positives in certain people at high risk for HIV
  • 39. Oral Testing  Orasure  The only FDA approved HIV antibody.  As accurate as blood testing  Draws blood-derived fluids from the gum tissue.  NOT A SALIVA TEST!
  • 41. HAART = highly active anti-retroviral treatment
  • 42. Antiretroviral Drugs (HAART)  Nucleoside Reverse Transcriptase inhibitors  AZT (Zidovudine)  Non-Nucleoside Transcriptase inhibitors  Viramune (Nevirapine)  Protease inhibitors  Norvir (Ritonavir)
  • 43. HEALTH CARE FOLLOW UP OF HIV INFECTED PATIENTS For all HIV-infected individuals:  CD4 counts every 3–6 months  Viral load tests every 3–6 months and 1 month following a change in therapy  PPD  INH for those with positive PPD and normal chest radiograph  RPR or VDRL for syphilis  Toxoplasma IgG serology  Cytomegalo virus IgG serology  Pneumococcal vaccine  Influenza vaccine in season  Hepatitis B vaccine for those who are HBsAb-negative  Haemophilus influenzae type b vaccination  Papanicolaou (cervical )smears every 6 months for women
  • 44. Conti…  For HIV-infected individuals with CD4 < 200 cells/mcL:  Pneumocystis jiroveci1 prophylaxis  For HIV-infected individuals with CD4 < 75 cells/mcL:  Mycobacterium avium complex prophylaxis  For HIV-infected individuals with CD4 < 50 cells/mcL:  Consider CMV prophylaxis
  • 45. PRIMARY PREVENTION: Five ways to protect yourself?  Abstinence  Monogamous Relationship  Protected Sex  Sterile needles  New shaving/cutting blades
  • 46. Abstinence  It is the most effective method of not acquiring HIV/AIDS.  Refraining from unprotected sex: oral, anal, or vaginal.  Refraining from intravenous drug use
  • 47. Monogamous relationship  A mutually monogamous (only one sex partner) relationship with a person who is not infected with HIV  HIV testing before intercourse is necessary to prove your partner is not infected
  • 48. Protected Sex  Use condoms every time you have sex  Always use latex or polyurethane condom (not a natural skin condom)  Always use a latex barrier during oral sex
  • 49. When Using A Condom Remember To:  Make sure the package is not expired  Make sure to check the package for damages  Do not open the package with your teeth for risk of tearing  Never use the condom more than once  Use water-based rather than oil-based condoms
  • 50. WHAT WE CAN DO?? UNAIDS Outcome Framework 2009–2011: nine priority areas  We can reduce sexual transmission of HIV.  We can prevent mothers from dying and babies from becoming infected with HIV.  We can ensure that people living with HIV receive treatment.  We can prevent people living with HIV from dying of tuberculosis.  We can protect drug users from becoming infected with HIV.  We can remove punitive laws, policies, practices, stigma and discrimination that  block effective responses to AIDS.  We can stop violence against women and girls.  We can empower young people to protect themselves from HIV.  We can enhance social protection for people affected by HIV.

Editor's Notes

  1. Vulnerable and High-risk Groups: -Expand knowledge, access, and coverage of vulnerable populations—particularly in large cities—to a package of high impact services, through combined efforts of the government and NGOs. -Implement harm-reduction initiatives for IDUs and safe sex practices for CSWs. -Make effective and affordable STD services available for high-risk groups and the general population.   General Awareness and Behavioral Change: -Undertake behavioral change communications with the following behavioral objectives: (i) use of condoms with non-regular sexual partners; (ii) use of STI treatment services when symptoms are present and knowledge of the link between STIs and HIV; (iii) use of sterile syringes for all injections; (iv) reduction in the number of injections received; (v) voluntary blood donation (particularly among the age group 18 to 30); (vi) use of blood for transfusion only if it has been screened for HIV; and (vii) display of tolerant and caring behaviors towards people living with HIV/AIDS and members of vulnerable populations. -Increase interventions among youth, police, soldiers, and migrant laborers.   Blood and Blood Product Safety: -Ensure mandatory screening of blood and blood products in the public and private sectors for all major blood-borne infections. -Conduct education campaigns to promote voluntary blood donation -Develop Quality Assurance Systems for public and private blood banks to ensure that all blood is properly screened for HIV and Hepatitis B.   Surveillance and Research: -Strengthen and expand the surveillance and monitoring system. -Implement a second-generation HIV surveillance that tracks sero-prevalence and changes in HIV-related behaviors, including the spread of STIs and HIV, sexual attitudes and behaviors, and healthcare-seeking behaviors related to STIs.   Building Management Capacity -Continue to build management capacity within provincial programs and local NGOs to ensure evidence-based program implementation. -Identify gaps in existing programs and continue phased expansion of interventions.